Introduction to PROTEkT: years 1-3 (1999-2002).
Harding
I
I
The Micron Group, Marmont Priory Farm, Upwell, Cambridgeshire PE14 9AR, UK. ian.harding@micron-research.com
D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D005602:France; D006801:Humans; D048628:Ketolides / Q000008:administration & dosage / Q000494:pharmacology*; D008137:Longitudinal Studies; D008826:Microbial Sensitivity Tests; D011358:Product Surveillance, Postmarketing; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D012680:Sensitivity and Specificity; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification
D048628:Ketolides; C106791:telithromycin